ST-1898

N/A

Report date: 2025/12/18 17:46:01
NME

Base Information

Drug NameST-1898
Drug Alias NameST-1898ACC-1898
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsMedullary thyroid cancer (MTC)Gastroesophageal Junction NeoplasmsSolid tumours +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Scitech-Mq Pharmaceuticals Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAccSalus Biosciences IncBeijing Scitech-Mq Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsMedullary thyroid cancer (MTC)Gastroesophageal Junction NeoplasmsSolid tumours +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A